FHL2 and neoplasm: Despite our finding that FHL2 silencing reduced osteosarcoma cell apoptosis in vitro and in vivo, we found that the overall effect of FHL2 silencing in vivo is to suppress tumor growth, indicating that FHL2 acts mostly as an oncoprotein in osteosarcoma cells.